<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="372363">
  <stage>Registered</stage>
  <submitdate>27/05/2017</submitdate>
  <approvaldate>27/09/2017</approvaldate>
  <actrnumber>ACTRN12617001372370</actrnumber>
  <trial_identification>
    <studytitle>Assessment of the effect of  intrathecal bupivacaine combined with opioids on postoperative analgesia in patients undergoing cesarean section
</studytitle>
    <scientifictitle>Assessment of the effect of  intrathecal bupivacaine combined with opioids (morphine, fentanyl) on postoperative analgesia in patients undergoing cesarean section</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>postoperative analgesia</healthcondition>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Childbirth and postnatal care</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Other surgery</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The patients ' demographic data were recorded.  Patients distributed to groups with closed envelope technique. The patients divided into three groups.
 according to the administered opioids that they receive:
 
Group II: 8 mg 5% hyperbaric bupivacaine + 20 mcg fentanyl + 50 mcg morphine were administrated intrathecal prior to caesarean procedure by anaesthesiologist
Group III: 8 mg 5% hyperbaric bupivacaine + 20 mcg fentanyl + 100 mcg morphine were administrated intrathecal prior to caesarean procedure by anaesthesiologist

The effectiveness of spinal anesthesia was assessed with the hot-cold sensation test and Bromage scale.  The surgery was initiated when the sensorial block level reaches T4 dermatome. Intraoperative pain was monitored using the Visual Analog Scale (VAS).  The duration of effective analgesia till the first postoperative analgesic requirements, The additional analgesic requirement within the first 24- hours after the surgery, the amount of additional analgesics, and side effects (nausea, vomiting, pruritus, and headache) were evaluated and recorded. 
</interventions>
    <comparator>Group I: 8 mg 5% hyperbaric bupivacaine + 20 mcg Fentanyl were administrated intrathecal prior to caesarean procedure</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>time of first analgesic requirement
this information is taken from patients themselves</outcome>
      <timepoint>24 hours post surgery</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Adverse effects (itching, allergies, nausea, vomiting, urinary retention, constipation, respiratory depression, bradycardia, hypotension, dizziness i.e.)</outcome>
      <timepoint>during intraoperative process and 24 hours post surgery

Adverse events were recorded. If adverse events were recognized, They were evaluated according to Common Terminology Criteria for Adverse Events (CTC-AE) ver. 4.0.
This adverse events listed are assessed as recorded by treating clinician in the medical records
</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>- 18 years older 
-cesarean section under spinal anesthesia 
- who know Turkish and are cooperative 
- whose physical status is consistent with ASA II class 
-gestational age must be &gt;27 weeks</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>45</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-neurological disease
-preeclampsia, diabetes mellitus, infection on the surgical site,
 -disorders associated with bleeding/ clotting, severe agitation,
 -non-cooperation, rejection of regional anesthesia, 
-obesity (body mass index &gt;35 kg/m2),
 -height shorter:150 cm, 
 - known fetal abnormality, placenta previa, history of ablatio placentae, risk for growth retardation and meconium aspiration; pathology that may affect the acid-base balance, antepartum hemorrhage,
-Rh incompatibility
- hypersensitivity to local anesthetics
-history of frequent analgesic use
- allergy to any medicine in the projected study protocol.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment />
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1>True</masking1>
    <masking2>True</masking2>
    <masking3>True</masking3>
    <masking4>True</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate />
    <actualstartdate>1/04/2016</actualstartdate>
    <anticipatedenddate />
    <actualenddate>30/12/2016</actualenddate>
    <samplesize>1110</samplesize>
    <actualsamplesize>1090</actualsamplesize>
    <currentsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>31/12/2016</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Turkey</country>
      <state>bursa</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>derya karasu</primarysponsorname>
    <primarysponsoraddress>Bursa Yuksek Ihtisas Training Education Hospital Clinic of Anesthesiology and Reanimation 
Mimar Sinan Neighborhood /Emniyet Street/16310 Yildirim/Bursa
</primarysponsoraddress>
    <primarysponsorcountry>Turkey</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>mine akoz</fundingname>
      <fundingaddress>Bursa Yuksek Ihtisas Training Education Hospital Clinic of Anesthesiology and Reanimation 
Mimar Sinan Neighborhood /Emniyet Street/16310 Yildirim/Bursa
</fundingaddress>
      <fundingcountry>Turkey</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>derya karasu</fundingname>
      <fundingaddress>Bursa Yuksek Ihtisas Training Education Hospital Clinic of Anesthesiology and Reanimation 
Mimar Sinan Neighborhood /Emniyet Street/16310 Yildirim/Bursa
</fundingaddress>
      <fundingcountry>Turkey</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>canan yilmaz</sponsorname>
      <sponsoraddress>Bursa Yuksek Ihtisas Training Education Hospital Clinic of Anesthesiology and Reanimation 
Mimar Sinan Neighborhood /Emniyet Street/16310 Yildirim/Bursa
</sponsoraddress>
      <sponsorcountry>Turkey</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Purpose: Our prospective, randomized, double-blind study aimed to detect the effect of intrathecal bupivacaine combined with opioids on the postoperative analgesia in patients undergoing cesarean section.
Material and Methods:  1110 patients with gestational age over 37 weeks, over 18 years of age and who  undergoing elective cesarean section with spinal anesthesia were  into the following three groups according to intrathecal opioids: Group 1: 8 mg 5% hyperbaric bupivacaine and 20 mcg fentanyl, Group 2: 8 mg 5% hyperbaric bupivacaine and 20 mcg fentanyl + 50 mcg morphine, Group 3: 8 mg 5% hyperbaric bupivacaine and 20 mcg fentanyl + 100 mcg morphine. First analgesic requirement time,  intraoperative and postoperative side effects, intraoperative visual analog scale (VAS) were recorded.
Results: 1090 patients were included in the statistical evaluation. Intraoperative nausea and vomiting were significantly less in the Group 3 (p=0.047). Intraoperative pruritus was significantly higher in Group 3 compared to the other two groups (p&lt;0.001). There was no difference between the groups in terms of intraoperative VAS values.  Postoperative nausea, vomiting, pruritus, hypotension, bradycardia were similar among the groups. Patient satisfaction was lowest in Group 1 and highest in Group 3 (p&lt;0.001). The duration of first analgesia was short in Group 1 (p&lt;0.001). 
Conclusions: We concluded that, morphine added to bupivacaine and fentanyl for spinal anesthesia increased the duration of the first analgesic requirement and that 50 and 100 mcg of morphine were not superior to each other in terms of side effects and first analgesic duration.
</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Bursa Yuksek Ihtisas Training and Education Hospital Clinical Researc Ethics Committee</ethicname>
      <ethicaddress>Bursa Yuksek Ihtisas Training Education Hospital Clinic of Anesthesiology and Reanimation 
Mimar Sinan Neighborhood /Emniyet Street/16310 Yildirim/Bursa
</ethicaddress>
      <ethicapprovaldate>30/03/2016</ethicapprovaldate>
      <hrec>2011-KAEK-25 2016/06-02</hrec>
      <ethicsubmitdate>16/03/2016</ethicsubmitdate>
      <ethiccountry>Turkey</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>mine ak√∂z</name>
      <address>Bursa Yuksek Ihtisas Training and Education Hospital Clinic of Anesthesiology and Reanimation Mimar Sinan Neighborhood/ Emniyet Street/ 16310 Yildirim/Bursa</address>
      <phone>+905077069100</phone>
      <fax />
      <email>mineakoz@hotmail.com</email>
      <country>Turkey</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>derya karasu</name>
      <address>Bursa Yuksek Ihtisas Training and Education Hospital Clinic of Anesthesiology and Reanimation Mimar Sinan Neighborhood/ Emniyet Street/ 16310 Yildirim/Bursa</address>
      <phone>+905057281175</phone>
      <fax />
      <email>drderyatopuz@gmail.com</email>
      <country>Turkey</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>canan yilmaz</name>
      <address>Bursa Yuksek Ihtisas Training and Education Hospital Clinic of Anesthesiology and Reanimation Mimar Sinan Neighborhood/ Emniyet Street/ 16310 Yildirim/Bursa</address>
      <phone>+905059045989</phone>
      <fax />
      <email>dr_cnnylmz@yahoo.com</email>
      <country>Turkey</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>